Form 4: CVS Health Director John Gallina Acquires Stock Units
Statement of Changes in Beneficial Ownership
CVS Health director John E. Gallina acquired 1,447.5039 deferred stock units as part of the company's non-employee director compensation policy.
Summary
- Director John E. Gallina received 1,447.5039 deferred stock units on May 14, 2026.
- The units were issued in lieu of a semi-annual cash retainer for board service.
- The transaction was valued at $97.15 per share based on the market price at the time of issuance.
- Each unit is convertible into one share of CVS Health common stock upon future distribution.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.
Positives
- Demonstrates alignment between board members and shareholders through equity-based compensation.
Future Outlook
The deferred stock units will be converted into common stock at a future date as elected by the reporting person.
Industry Context
StockSavvy.ai notes that this is a routine disclosure of director compensation, common among large-cap public companies to ensure board members maintain a financial stake in the company's performance.
Comparison to Industry Standards
- The use of deferred stock units for director compensation is a standard practice among S&P 500 companies to align director interests with long-term shareholder value.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation | Issuance of deferred stock units under the 2017 Incentive Compensation Plan. | 05/14/2026 | Standard alignment of director compensation with equity performance. |
Stakeholder Impact
- Minimal impact on shareholders as this is a standard compensation mechanism.
Next Steps
- Future conversion of deferred stock units into common stock upon the director's election.
Key Dates
| Date | Description |
|---|---|
| 05/14/2026 | Date of the transaction involving deferred stock units. |
| 05/15/2026 | Date the Form 4 was signed and filed. |
Keywords
CVS Health, Form 4, Insider Trading, Director Compensation, Equity Incentive Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.